Abstract

Amazingly little sequence variation is reported for the kringle IV 2 copy number variation (KIV 2 CNV) in the human LPA gene. Apart from whole genome sequencing projects, this region has only been analyzed in some detail in samples of European populations. We have performed a systematic resequencing study of the exonic and flanking intron regions within the KIV 2 CNV in 90 alleles from Asian, European, and four different African populations. Alleles have been separated according to their CNV length by pulsed field gel electrophoresis prior to unbiased specific PCR amplification of the target regions. These amplicons covered all KIV 2 copies of an individual allele simultaneously. In addition, cloned amplicons from genomic DNA of an African individual were sequenced. Our data suggest that sequence variation in this genomic region may be higher than previously appreciated. Detection probability of variants appeared to depend on the KIV 2 copy number of the analyzed DNA and on the proportion of copies carrying the variant. Asians had a high frequency of so-called KIV 2 type B and type C (together 70% of alleles), which differ by three or two synonymous substitutions respectively from the reference type A. This is most likely explained by the strong bottleneck suggested to have occurred when modern humans migrated to East Asia. A higher frequency of variable sites was detected in the Africans. In particular, two previously unreported splice site variants were found. One was associated with non-detectable Lp(a). The other was observed at high population frequencies (10% to 40%). Like the KIV 2 type B and C variants, this latter variant was also found in a high proportion of KIV 2 repeats in the affected alleles and in alleles differing in copy numbers. Our findings may have implications for the interpretation of SNP analyses in other repetitive loci of the human genome.

Highlights

  • IntroductionLipoprotein(a) (Lp(a)) is a complex particle in human plasma

  • Lipoprotein(a) (Lp(a)) is a complex particle in human plasma. It is assembled from a low density lipoprotein (LDL) and a glycoprotein, apolipoprotein (apo(a)), which is encoded by the LPA gene (MIM +152200)

  • No sequence variation was observed in the exonic region and the immediate flanking intron sequence of KIV-2 exon 1 (K421) in any of the clones

Read more

Summary

Introduction

Lipoprotein(a) (Lp(a)) is a complex particle in human plasma. It is assembled from a low density lipoprotein (LDL) and a glycoprotein, apolipoprotein (apo(a)), which is encoded by the LPA gene (MIM +152200). Lp(a) levels in plasma range from 100 mg/dl, but are highly heritable. The mean concentrations vary considerably between ethnic groups, with Africans exhibiting on average two- to threefold higher Lp(a) levels compared to Europeans. LPA is the major gene controlling this quantitative and co-dominantly expressed trait. The physiological function of Lp(a)/apo(a) is still unknown, whereas its association with coronary heart disease is well established (for review see [1])

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call